Yangfan Xiao

Audit Supervisor @ Hengrui Pharma

About

Multidisciplinary life-science professional with an MS in Chronic Disease Epidemiology from Yale and hands-on experience spanning clinical trial regulatory affairs and wet-lab drug discovery. Skilled at: - Distilling complex clinical/preclinical data into clear, strategic insights for evidence-based decisions - Designing biochemical & cell-based assays to identify herbal oncology/immunology candidates - Collaborating with cross-functional teams in academia (Yale Pharmacology) and industry (Yiviva) Passionate about translating bench-side discoveries into rigorously tested therapeutics. Let’s connect to make a better world for the patients!

Country

United States

City

New Haven

Industry

Biotechnology

Skill

Regulatory Affairs, Clinical Trials, Data Analysis, Drug Discovery, Biochemistry, Epidemiology, Literature Reviews, Epigenetics, SAS (Software), R (Programming Language), Python (Programming Language), Photography

Experience

Audit Supervisor

Hengrui Pharma

2026-1 - Present · 9 mos

Shanghai, China

Research Regulatory Assistant

Yiviva

2023-7 - 2025-12 · 2 yrs 6 mos

New Haven, Connecticut, United States

-Reviewed 100+ TFLs, a 130-page CSR, and patient narratives to extract safety/efficacy insights and drive FDA/NMPA submission readiness -Conducted comparative analyses of FDA-approved therapies across 6 indications and led site-feasibility and regional regulatory assessments to inform company R&D strategic decisions -Generated 100+ data visualizations (KM, PK, TRAE charts) and pioneered a drug exposure–AE analytic method for enhanced safety insights -Screened 400+ herbal candidates against 6 key oncology/immunology pathways via biochemical and cell-based assays, bridging bench discoveries toward clinical evaluation